CITIC Securities Co., Ltd. (600030.SH) Latest Company News

Sep 19, 2026, 06:50 UTC
Huawei held its Connect Conference on September 17-18, 2026, unveiling new AIDC energy and thermal management products including Taishan UPS, Hengshan centralized DC UPS, Power Module 5.0, Smart Lithium Battery 5.0 and an AI intelligent liquid cooling system.
Source:
- finance.sina.cn
Sep 18, 2026, 14:26 UTC
Zhejiang Jingxin Pharmaceutical filed an application for listing with the Hong Kong Stock Exchange, with CITIC Securities as sole sponsor.
Source:
- finance.sina.cn
- finance.sina.cn
Sep 18, 2026, 08:20 UTC
Hunan Yujia Investment Management, controlling shareholder of Shuiyang Co., pledged 10 million shares (2.27% of total share capital) to CITIC Securities for shareholder funding needs, starting September 17, 2026.
Source:
- finance.sina.cn
Sep 18, 2026, 02:18 UTC
On September 18, Chinese brokerage stocks listed in Hong Kong rose broadly, with Guotai Haitong up 2%, CITIC Securities and China Securities up 1.6%, and CICC, GF Securities, China Galaxy, Shenwan Hongyuan, Orient Securities and Guolian Minsheng each up 1%.
Source:
- aastocks.com
Sep 17, 2026, 23:55 UTC
CITIC Securities saw a net margin repayment of 47.3305 million yuan on September 17, 2026, with its margin financing balance at 18.32 billion yuan, or 5.75% of its free-float market capitalization.
Source:
- wap.eastmoney.com
Sep 17, 2026, 13:59 UTC
The Federal Reserve began raising interest rates, ending its easing cycle, according to a CITIC Securities research report.
Source:
Sep 17, 2026, 09:54 UTC
Bank of Changsha announced that 870,129 IPO restricted shares held by 18 shareholders will become tradable on September 28, 2026, clearing all restricted shares and raising unrestricted shares to 4,021,553,754.
Source:
- finance.sina.cn
Sep 16, 2026, 10:45 UTC
Sichuan Biokin Pharmaceutical reported H1 2026 revenue of 187 million yuan, up 9.43% year on year, a net loss of 1.637 billion yuan, and R&D investment of 1.483 billion yuan.
Source:
- finance.sina.cn
Sep 16, 2026, 06:48 UTC
Shenzhen Dapu Micro is reportedly selecting banks for its Hong Kong listing, planning to choose CITIC, Haitong and UBS to work on its Hong Kong share sale.
Sep 16, 2026, 01:53 UTC
Jinjing Technology completed a 300 million yuan Series B funding round led by existing shareholder Kangyu Capital and Fujiang Capital, with participation from Transfar Group, CITIC Jinshi and Xiang Guanglong.
Source:
- finance.sina.cn
Sep 16, 2026, 01:30 UTC
Aike Micro Technology (Shanghai) Co., Ltd. completed its pre-IPO tutoring and moved to the tutoring acceptance stage for its planned initial public offering, with CITIC Securities as the tutoring institution.
Source:
- finance.sina.cn
Sep 16, 2026, 01:15 UTC
Zhejiang Xingxing Cold Chain Integration Co., Ltd. filed IPO coaching registration with the Zhejiang Securities Regulatory Bureau on 2026-09-15, with CITIC Securities as coaching broker, restarting its plan for an initial public offering and listing.
Source:
- finance.sina.cn
Sep 15, 2026, 23:27 UTC
A-share IPO underwriting volume in 2026 has already surpassed the full-year 2025 total, with CICC leading by underwriting amount, CITIC Securities ranking notably higher than mid-year, and Guotai Haitong leading by number of deals.
Source:
- finance.sina.cn
Sep 15, 2026, 19:33 UTC
Pulike Pharmaceutical (Jiangsu) Co., Ltd. again submitted a listing application to the Hong Kong Stock Exchange, applying for a main board listing under the 18A biotech company rules, with CITIC Securities as sole sponsor.
Source:
- nbd.com.cn
Sep 15, 2026, 10:54 UTC
Hengbo Co., Ltd. reported that its revenue for the first half of 2026 rose 61.16% year over year while net profit attributable to shareholders fell 28.01%.
Source:
- finance.sina.cn
Sep 15, 2026, 09:13 UTC
CITIC Securities received approval from the China Securities Regulatory Commission to publicly issue perpetual subordinated bonds with a total face value of no more than 40 billion yuan to professional investors.
Source:
- finance.sina.cn
Sep 15, 2026, 02:42 UTC
China's National Healthcare Security Administration held a symposium in Beijing on the pilot pre-approval system for medical service pricing items, with about 70 participants from hospitals, companies, investment institutions and media.
Source:
- finance.sina.cn
Sep 15, 2026, 00:03 UTC
China's July nationwide electricity consumption growth slowed to 1.7% year-on-year, with residential electricity use down 5.1%, while thermal power utilization hours fell 8.5% year-on-year.
Source:
- finance.sina.cn
Sep 14, 2026, 13:54 UTC
Datang International Power Generation replied to the Shanghai Stock Exchange's review inquiry letter regarding its planned private placement of up to RMB 8 billion in shares to specific investors.
Source:
- nbd.com.cn
Sep 14, 2026, 11:52 UTC
On September 14, Chinese A-share and Hong Kong innovative-drug sector ETFs rose, with Hong Kong innovative-drug-related ETFs such as Harvest Hong Kong Stock Connect Innovative Drug ETF and Southern Hang Seng Biotech ETF gaining over 4%.
Source:
- finance.ifeng.com
- fund.eastmoney.com
Sep 14, 2026, 09:25 UTC
Zhongxin Co., Ltd. announced that 930,653 strategic placement restricted shares held by China Insurance Investment Fund (Limited Partnership) will become tradable on September 21, 2026, representing 0.65% of total share capital.
Source:
- finance.sina.cn
Sep 14, 2026, 08:41 UTC
Zijin Mining's acquisition of control of Chifeng Jilong Gold Mining is proceeding, with CITIC Securities replacing the independent financial advisor supervisors on the project.
Source:
- finance.sina.cn
Sep 8, 2026, 10:37 UTC
Yonghe Co., Ltd. announced that 7,894,736 restricted shares subscribed by controlling shareholder Tong Jianguo in a private placement will be unlocked and listed for trading on September 15, 2026, representing 1.55% of total share capital.
Source:
- finance.sina.cn
- wap.eastmoney.com
Sep 2, 2026, 03:19 UTC
On September 2, 2026, Chinese brokerage stocks listed in Hong Kong fell collectively, with CITIC Securities down 4% and China International Capital Corporation down 6.5%.
Source:
- aastocks.com
Aug 31, 2026, 14:37 UTC
Pulai Pharmaceutical (Jiangsu) Co., Ltd. - B submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor.
Source:
- finance.sina.cn
Aug 31, 2026, 14:08 UTC
Ningbo Shunyu Zhixing Technology Co., Ltd. filed a listing application with the Hong Kong Stock Exchange for an IPO, with CICC and CITIC Securities as joint sponsors.
Source:
- finance.sina.cn
Aug 28, 2026, 14:39 UTC
Betta Pharmaceuticals Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor.
Source:
- finance.sina.cn
Aug 26, 2026, 02:23 UTC
On August 26, 2026, Chinese brokerage stocks in Hong Kong collectively rose, with China International Capital Corporation up 6%, China Merchants Securities up 5%, China Galaxy up 4.5%, CITIC Securities up 4.4%, and others gaining over 2-3%.
Source:
- aastocks.com
Aug 4, 2026, 08:49 UTC
CICC submitted a registration application to publicly issue 80 billion yuan of corporate bonds to professional investors, with underwriters including CITIC Securities, Huatai United Securities, CSC Financial, and China Galaxy Securities.

Page 1Next →

600030.SH

Huawei held its Connect Conference on September 17-18, 2026, unveiling new AIDC energy and thermal management products including Taishan UPS, Hengshan centralized DC UPS, Power Module 5.0, Smart Lithium Battery 5.0 and an AI intelligent liquid cooling system.

Zhejiang Jingxin Pharmaceutical filed an application for listing with the Hong Kong Stock Exchange, with CITIC Securities as sole sponsor.

Hunan Yujia Investment Management, controlling shareholder of Shuiyang Co., pledged 10 million shares (2.27% of total share capital) to CITIC Securities for shareholder funding needs, starting September 17, 2026.

On September 18, Chinese brokerage stocks listed in Hong Kong rose broadly, with Guotai Haitong up 2%, CITIC Securities and China Securities up 1.6%, and CICC, GF Securities, China Galaxy, Shenwan Hongyuan, Orient Securities and Guolian Minsheng each up 1%.

CITIC Securities saw a net margin repayment of 47.3305 million yuan on September 17, 2026, with its margin financing balance at 18.32 billion yuan, or 5.75% of its free-float market capitalization.

The Federal Reserve began raising interest rates, ending its easing cycle, according to a CITIC Securities research report.

Bank of Changsha announced that 870,129 IPO restricted shares held by 18 shareholders will become tradable on September 28, 2026, clearing all restricted shares and raising unrestricted shares to 4,021,553,754.

Sichuan Biokin Pharmaceutical reported H1 2026 revenue of 187 million yuan, up 9.43% year on year, a net loss of 1.637 billion yuan, and R&D investment of 1.483 billion yuan.

Shenzhen Dapu Micro is reportedly selecting banks for its Hong Kong listing, planning to choose CITIC, Haitong and UBS to work on its Hong Kong share sale.

Jinjing Technology completed a 300 million yuan Series B funding round led by existing shareholder Kangyu Capital and Fujiang Capital, with participation from Transfar Group, CITIC Jinshi and Xiang Guanglong.

Aike Micro Technology (Shanghai) Co., Ltd. completed its pre-IPO tutoring and moved to the tutoring acceptance stage for its planned initial public offering, with CITIC Securities as the tutoring institution.

Zhejiang Xingxing Cold Chain Integration Co., Ltd. filed IPO coaching registration with the Zhejiang Securities Regulatory Bureau on 2026-09-15, with CITIC Securities as coaching broker, restarting its plan for an initial public offering and listing.

A-share IPO underwriting volume in 2026 has already surpassed the full-year 2025 total, with CICC leading by underwriting amount, CITIC Securities ranking notably higher than mid-year, and Guotai Haitong leading by number of deals.

Pulike Pharmaceutical (Jiangsu) Co., Ltd. again submitted a listing application to the Hong Kong Stock Exchange, applying for a main board listing under the 18A biotech company rules, with CITIC Securities as sole sponsor.

Hengbo Co., Ltd. reported that its revenue for the first half of 2026 rose 61.16% year over year while net profit attributable to shareholders fell 28.01%.

CITIC Securities received approval from the China Securities Regulatory Commission to publicly issue perpetual subordinated bonds with a total face value of no more than 40 billion yuan to professional investors.

China's National Healthcare Security Administration held a symposium in Beijing on the pilot pre-approval system for medical service pricing items, with about 70 participants from hospitals, companies, investment institutions and media.

China's July nationwide electricity consumption growth slowed to 1.7% year-on-year, with residential electricity use down 5.1%, while thermal power utilization hours fell 8.5% year-on-year.

Datang International Power Generation replied to the Shanghai Stock Exchange's review inquiry letter regarding its planned private placement of up to RMB 8 billion in shares to specific investors.

On September 14, Chinese A-share and Hong Kong innovative-drug sector ETFs rose, with Hong Kong innovative-drug-related ETFs such as Harvest Hong Kong Stock Connect Innovative Drug ETF and Southern Hang Seng Biotech ETF gaining over 4%.

Zhongxin Co., Ltd. announced that 930,653 strategic placement restricted shares held by China Insurance Investment Fund (Limited Partnership) will become tradable on September 21, 2026, representing 0.65% of total share capital.

Zijin Mining's acquisition of control of Chifeng Jilong Gold Mining is proceeding, with CITIC Securities replacing the independent financial advisor supervisors on the project.

Yonghe Co., Ltd. announced that 7,894,736 restricted shares subscribed by controlling shareholder Tong Jianguo in a private placement will be unlocked and listed for trading on September 15, 2026, representing 1.55% of total share capital.

On September 2, 2026, Chinese brokerage stocks listed in Hong Kong fell collectively, with CITIC Securities down 4% and China International Capital Corporation down 6.5%.

Pulai Pharmaceutical (Jiangsu) Co., Ltd. - B submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor.

Ningbo Shunyu Zhixing Technology Co., Ltd. filed a listing application with the Hong Kong Stock Exchange for an IPO, with CICC and CITIC Securities as joint sponsors.

Betta Pharmaceuticals Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor.

On August 26, 2026, Chinese brokerage stocks in Hong Kong collectively rose, with China International Capital Corporation up 6%, China Merchants Securities up 5%, China Galaxy up 4.5%, CITIC Securities up 4.4%, and others gaining over 2-3%.

CICC submitted a registration application to publicly issue 80 billion yuan of corporate bonds to professional investors, with underwriters including CITIC Securities, Huatai United Securities, CSC Financial, and China Galaxy Securities.